Abstract
This chapter summarizes the influence of polyelectrolyte topology on biological functions and biomedical applications such as cell uptake, drug delivery, and gene transfection. Polyelectrolytes utilized are spherical structures derived from dendrimers and albumin or cylindrical brushes, all of which are decorated with various polypeptide chains.
First, experiments are described that address the role of polyelectrolyte interactions on endosomal uptake and release, followed by a discussion of the novel design of albumin-based nanocarriers for anticancer drugs like doxorubicin. Finally, we describe how efficient gene transfection was accomplished with both albumin-based polycations and with cylindrical brushes having poly-l-lysine side chains.
Similar content being viewed by others
Keywords
- Brain
- Cylindrical brush polymer
- Dendritic and protein polyelectrolytes
- Endothelial cell
- Flow cytometry
- Gene transfer
- Polycation
- Transfection
1 Exploring Cell Interactions of Dendritic and Protein Polyelectrolytes
1.1 Introduction
Ionic interactions play a crucial role in many cellular processes such as membrane permeation or regulation of gene transcription [1]. The cell membrane, with its bilayer and negatively charged surface, serves as a protective barrier for the living cell towards its environment. Hydrophobic or positively charged molecules can interact with the cell membrane and can enter cells via various mechanisms [2]. In the cell nucleus, polycationic proteins and histones form complexes with DNA and regulate transcription through alteration of the charge densities of nuclear proteins and DNA [3]. Inspired by these polyelectrolytic interactions in nature, synthetic nanosized polyelectrolytes have been designed that contain multiple electrolyte groups, i.e., polycations or polyanions. Some of these polyelectrolyte carriers have already been successfully explored for biomedical applications such as gene or cancer therapy [4, 5]. With greater emphasis on defined macromolecular architectures of the materials, regularly branched cascade molecules (so-called dendrimers) and protein-based polyelectrolytes have emerged over the past decade. Their interactions with cells have been analyzed to elucidate the role of polyelectrolyte interactions in nature and to apply this knowledge for the design of efficient and biocompatible nanotransporters for the delivery of cargoes such as drugs, proteins, or nucleic acids into cells and subcellular compartments [6, 7].
Endocytosis is essential for uptake of macromolecules and nanoparticles. Thereby, the physical and chemical characteristics of the cargo and transporter complex determine the nature of the cell uptake mechanism. Particles larger than 500 nm are typically phagocytosed or macropinocytosed, whereas smaller hydrophilic molecules are internalized by any of the various endocytotic processes [2, 8]. Often, nanometer-sized transporter molecules or particles accomplish cell uptake simultaneously by several endocytotic mechanisms [9]. Clathrin-dependent endocytosis is the most widely understood pathway, which is present in nearly all mammalian cells. The clathrin pathway is considered the most important uptake mechanism for several polymers such as poly(ethylene glycol)-polylactides, poly(lactide-co-glycolide) (PLGA), silica-based nanoparticles, and chitosan nanoparticles [8, 10–12].
Besides clathrin-mediated cell uptake, caveolae-mediated endocytosis is another well-investigated uptake mechanism. The caveolae pathway is particularly attractive for the delivery of proteins and nucleic acids because these vesicles have neutral pH and the lysosomes, where degradation takes place, are bypassed [8, 13]. Nanoparticles described to be mainly endocytosed by caveolae include polymeric micelles with a crosslinked anionic core, DOXIL, polysiloxanes, coated quantum dots, and Abraxane [8, 14–17].
Apart from clathrin- and caveolin-mediated endocytosis, there also exist multiple other pathways independent of clatherin and caveoli-1 that also play an important role in nanoparticle endocytosis. Exploring the clathrin- and caveolin-independent uptake mechanisms has only recently gained attention in endocytosis research, and these less-understood uptake mechanisms might have implications for drug delivery research.
In this chapter, the design of structurally defined dendritic and protein-based polyelectrolyte nanocarriers is presented and the impact of their macromolecular architectures and the presence of multiple charges and charge densities on cellular uptake, trafficking, and cell toxicity is discussed.
1.2 Polycationic and Polyanionic Core–Shell Polyphenylene Dendrimers
Polycationic proteins such as nuclear histone proteins possess high densities of the positively charged amino acids lysine and arginine located at their periphery, as well as a lipophilic interior. These “natural” polycations are able to complex and to store DNA in the cell nucleus. Based on these structural considerations, dendritic core–shell macromolecules have been designed that possess a lipophilic and relatively stiff polyphenylene scaffold that determines the size and the shape of the macromolecules, as well as a second polymer shell containing multiple positive or negative charges (Fig. 1a) [18]. The position of these charged polymer chains at the dendrimer surface is predetermined by molecular design. The approximate number of charged groups (monomer units) within the polymer chains has been varied by atom transfer radical polymerization (ATRP). In this way, structurally defined macromolecules have been obtained that allow the qualitative correlation of the impact of the architecture and the number and nature of charges of a globular macromolecule on its ability to cross biological membranes [18]. As an additional structural feature, the lipophilic inner part contains a fluorescent perylene-3,4,9,10-tetracarboxdiimide (PDI) chromophore to allow cell uptake studies by fluorescence microscopy (Fig. 1b, c). Polycationic and polyanionic shells have been achieved after polymerization of 2-tert-butoxycarbonylaminoethyl methacrylate or tert-butyl acrylate, respectively, from the inner polyphenylene core that serves as macroinitiator carrying a defined number of 2-bromo-2-methylpropionic ester groups [18]. After removal of the tert-butoxycarbonyl or tert-butyl protective groups, the synthesized core–shell macromolecules possesses good water solubility, which is essential for in vitro cell experiments.
The impact of the macromolecular architecture on cell uptake and toxicity revealed that the presence of positively charged primary amino groups is essential for efficient membrane uptake, since none of the polyanions was taken up by cells. The total number of grafted polymer chains as well as the polymer chain lengths (e.g., the number of aminoethyl groups per chain) have been varied systematically [18]. Even though all polycations were in principle able to enter cells, increasing the number of cationic repeat units (amino groups) prolonged the time required for cell uptake. In addition, the macromolecular architecture also played an important role. For those polycations with higher densities of polymer chains at the surface of the dendrimers, significantly faster cell uptake was observed but there was also more efficient exocytosis, resulting in lower intracellular concentrations compared to the polycations with lower numbers of polymer chains. In addition, all macromolecules containing a high number and high density of amino groups showed considerable cytotoxicity, most probably due to vesicle leakage and cell lysis [19], which has been reported for other polycationic macromolecules as well.
The polycationic core–shell macromolecule 4 (Fig. 2b), formed from a first -generation dendrimer with 50 monomer repeating units, revealed only minor cell toxicity and was investigated with regard to its potential to interact with subcellular structures [20]. An interaction with the highly negatively charged extracellular matrix (ECM) was observed at physiological pH [20]. Because the ECM surrounds cells and plays an important role in many aspects of cellular fate (including cell migration, stem cell differentiation, and cancer progression) specific labeling of the ECM could be attractive for cell studies. Via affinity analysis, aggrecan was identified as a major interaction partner [20]. Aggrecan is a major structural proteoglycan of cartilage ECM, with a 210–250 kDa core protein to which 100–150 chondroitin sulfate and keratan sulfate chains are attached [21, 22]. In a dot blotting assay, only negatively charged aggrecan was found to interact with the polycationic dendrimer, most probably due to the presence of multiple positive charges. Visualization of the microstructure of the ECM in both fixed and living preparations indicated strong binding to its negatively charged constituents (Fig. 2). Interestingly, the polycationic dye 4 revealed significantly increased emission intensity after binding to the ECM components, and this observation was even compatible with antibody staining, making it useful for multiple channel fluorescence imaging. Due to the observed biological specificity, such polycationic chromophores could serve as an attractive tool for specifically labeling the ECM in life science research [20].
Complex formation of polycationic core–shell macromolecules with natural polyanions such as DNA has been investigated. Three generations of core–shell polymers consisting of a dendritic polyphenylene core and an outer shell containing a defined number of primary amino groups have been synthesized via ATRP (Fig. 2a shows structures 3a and 3b, generations 1 and 2, respectively) [23]. All polymers revealed tight binding to different sets of DNA fragments as well as plasmid DNA pUK19 (2,686 bp; 5,372 negative charges). Complex stoichiometries between pUK19 and the polymers were determined by isothermal titration calorimetry and it turned out that the presence of increasing numbers of amino groups within the polymer shell resulted in the formation of polyelectrolyte complexes with higher DNA contents. The average number of dendrimer molecules per pUC19 DNA helix in a complex decreased from 98 (3a with about 55 amino groups), to 46 (3b with about 116 amino groups) to 30 (third generation dendrimer with about 197 amino groups) under the assumption that neutral complexes were formed [23]. In this way, complex stoichiometries could be controlled by tuning the number of amino groups of the dendritic polycations under the formation of well-defined nanoscopic architectures. Additionally to DNA binding, the question of DNA release was also addressed in this study. A salt concentration-dependent DNA release was achieved with increasing salt concentrations from 50 mM up to 1 M, with complete DNA release at the highest concentrations. These polycationic core–shell dendrimers provide many attractive features such as multiple and adjustable positive charges, allowing high capacity binding and release of nucleic acids, which makes them an interesting tool for DNA staining, gene transfection, and DNA purification.
In contrast, polyanionic core–shell dendrimers such as 5 (Fig. 3a) did not display any cellular uptake and, therefore, it was not feasible to investigate the fate of these polyanions inside viable cells [18]. However, applying them to fixed cells allowed cell membrane uptake and specific staining of the cell nuclei in Drosophila tissue (Fig. 3b) [20]. In the cell nucleus, DNA wraps around histone proteins forming nucleosomes. The role of histone proteins is to pack and order DNA into structural units based on electrostatic interactions with DNA, which has an important impact for gene transcription. In the presence of the polyanionic core–shell macromolecule 5, bearing high numbers of negatively charged carboxylate groups, DNA is most probably displaced from the complexes and polyelectrolyte complexes between 5 and the histone H1 proteins are formed due to tight interactions (Fig. 3c). 5 specifically stains the cell nucleus by binding to the positively charged nuclear proteins (Fig. 3d), and it might therefore serve as an attractive alternative to conventional fluorescent antibodies. Polyanionic core–shell dendrimers combine unique properties such as water solubility, high photochemical stability, narrow emission spectra, and cell-specific binding, making them attractive for cytochemical and histochemical studies.
1.3 Polycationic Serum Albumin Proteins for Gene Delivery
As discussed above, many synthetic polycations exhibit high cellular toxicities, even at low concentrations. Interestingly, polycationic proteins such as nuclear histone proteins are often much less cytotoxic, which might be due to the presence of many other functional groups within the polypeptide scaffold that potentially “dilute” the effect of the positive charges. In order to assess the impact of the positive charges of polycationic proteins on cell uptake and cell toxicity, polycationic derivatives of the abundant blood plasma protein transporter serum albumin were prepared [6]. Serum albumin is well suited to impart chemical surface modifications due to the high number of negatively charged amino acids (e.g., 100 glutamate and aspartate groups), its diameter of 4.7 nm calculated from the crystal structure [6], and the presence of lipophilic pockets that can accommodate lipophilic guest molecules. Albumin polycations have been achieved by successive conversion of carboxylic acid side chains of the negatively charged amino acids of aspartate and glutamate residues into primary amino groups (Fig. 4) [6]. Stepwise reaction of the carboxylic acid groups with increasing amounts of ethylenediamine and catalyst allowed the synthesis of albumin polycations with varying charge densities. The albumin polycations are denoted according to their modification, e.g., cBSA-147 is cationized bovine serum albumin with 147 additional primary amino groups that have been introduced by chemical modification.
With increasing charge density, more efficient cellular uptake of the polycationic BSA derivatives has been found and the highest polycationic albumin cBSA-147 revealed the most efficient uptake into A549 cells [6]. Interestingly, even at high cBSA-147 concentrations only low cytotoxicity has been found. Cell uptake proceeds mostly via clathrin-mediated endocytosis, which can be inhibited with chlorpromazine hydrochloride. Rhodamine-labeled cBSA-147 escapes the endosome and is detected in the cytosol as well as in the perinuclear region (Fig. 4). With increasing numbers of primary amino groups, proteolytic stability versus trypsin or proteinase K digestion decreases. Due to the high positive net charge of the albumin polycations, complex formation with plasmid DNA encoding for the green fluorescent protein (pDNA-GFP) has been observed for cBSA-95, cBSA-113, and cBSA-147 derivatives. The latter, in particular, forms stable complexes with plasmid DNA [6]. Isothermal titration calorimetry experiments investigating complex formation were used to assess the relative stoichiometries of the protein/DNA complexes in solution (Fig. 4). Similar to the results observed for the dendritic core–shell polycations, increasing numbers of positive charges facilitated the formation of polyelectrolyte with less cBSA proteins and increased DNA contents. In addition, cBSA-147 binds pDNA-GFP very efficiently and complex dissociation constants in the low nanomolar range (below the detection limit) have been calculated. Varying the ratio of positive (cBSA) versus negative (DNA) charges (P/N) of cBSA and pDNA-GFP has an important impact on complex morphologies: at high P/N rates, DNA is tightly bound and condensed by many polycationic albumins and small, dense complexes as well as low transfection rates have been detected. Equal P/N ratios yield larger complexes containing fewer polycations and high transfection efficacies have been observed (Fig. 4). Most likely, such complexes allow more efficient release of the DNA cargo due to the formation of less densely packed complexes. This study clearly demonstrates that high numbers of amino groups on cBSA are essential for DNA complex formation but that the number of cBSA molecules in the complexes should be low to facilitate efficient DNA transfection and release. Also, cBSA-147/DNA complexes at low P/N charge ratios reveal considerably reduced cytotoxicity compared to the commercially available transfection reagent Lipofectamine.
In addition, more sophisticated albumin polycation architectures have been designed. Serum albumins offer a single reactive thiol group that is accessible for site-directed chemistry, e.g., Michael reactions with a maleimide functionality that can react exclusively at this position. Two cBSA-147 molecules have been interconnected by a poly(ethylene oxide) (PEO) polymer linker and the successful formation of the cBSA dimers has been visualized by transmission electron microscopy (TEM). These cBSA-dimers revealed efficient cellular uptake as well as transfection of pDNA-GFP.
Furthermore, polycationic albumins have been investigated for the immobilization of viable cells based on electrostatic interactions. cBSA-147, which is readily available on a large scale, allows coating of the walls of a microchannel reactor so that bacterial cells can attach with high cell densities. These whole-cell catalysts are able to enantioselectively reduce ethyl acetoacetate to R-ethyl hydroxybutyrate for several days with high productivity and revealed a better profile than the standard polylysine coating [24]. In addition, giant liposomes have been immobilized on cBSA-coated surfaces, which is attractive for in vitro protein synthesis [25]. Coating of primary human cells proved to be less efficient. However, the attachment of cyclic RGD groups to cHSA (cationized human serum albumin) interacting with integrin receptors allowed the immobilization of NIH 3 T3 fibroblast cells, which could have a great impact for, e.g., coating implants with a more biocompatible human protein platform [26].
Biopolymers like cBSA offer many reactive groups suitable for multiple surface modifications, making them useful not only for gene delivery but also for drug delivery. Efficient drug delivery is still a high concern of health research because many treatment strategies are still limited by low drug concentrations at the target site or by significant side effects due to high drug doses. Drug delivery systems based on macromolecules such as polymers, dendrimers, or proteins have thus been developed for passive targeting of cancerous cells. These systems make use of the characteristic features of tumor biology that allow the macromolecules to accumulate in the tumor through the enhanced retention and permeation (EPR) effect [27]. The molecular size of the macromolecule plays an important role in tumor cell uptake and the EPR effect is typically observed for macromolecules with molecular weight greater than 20 kDa [28, 29]. Serum albumins are carriers of fatty acids in the blood and, due to their ability to bind to various exogenous and endogenous ligands, they are one of the most exploited proteins for use as a drug delivery vehicle [30, 31] in therapeutics and clinical biochemistry [32], especially for the delivery of lipophilic drug molecules and in particular lipophilic antitumor drugs. HSA drug conjugates are commercially available, e.g., as HSA nanoparticle formulations with the drug paclitacel (Abraxane) [33]. In addition, HSA–drug conjugates have been achieved that combine the drug molecule and targeting ligands, and the potential of such modified serum albumins for receptor-mediated delivery of small lipophilic molecules has been investigated thoroughly. In this context, modified BSA and HSA molecules have been described as accommodating small drug molecules such as doxorubicin [34], camptothecin [35], and methotrexate [36].
In order to assess whether polycationic albumins still bear the lipophilic binding pockets that the native proteins offer, electron spin resonance experiments with spin-labeled fatty acids have been carried out [37]. Native HSA and BSA are able to bind about eight fatty acids within their scaffolds and their relative locations have been determined by EPR analysis. After cationization, the flexibility and mobility of the protein scaffold changed significantly, making cHSA considerably less flexible than native HSA. In addition, many fatty acid ligands are bound tightly to the surface of cHSA but none of these molecules has been found in the lipophilic binding pockets (Fig. 5a). It was speculated that the decreased mobility of the albumin scaffold might limit the capacity of cHSA to adapt to the shape of the guest molecules and that a sufficient flexibility might be required for guest uptake. However, it might be also plausible that the fatty acids are trapped on the surface of cHSA due to electrostatic interactions.
In order to dissipate the positive charges within a larger volume, polyamidoamine (PAMAM) dendrons have been attached to the HSA scaffold. PAMAM dendrimers are highly branched, structurally well-defined macromolecules with many primary amino groups within their outer shell. The dendritic branches that form a dendrimer are called dendrons. It has been shown before that PAMAM dendrimers are able to traffic into cells by clathrin-dependent endocytosis [38, 39]. The attachment of about 32 dendrons of the second and third generation to an azido-functionalized albumin by 1,3-dipolar cycloadditions yielded dendronized HSA core–shell macromolecules (DHSA-G2 and DHSA-G3) with positive net charges. Interestingly, EPR experiments indicate the accessibility of the binding pockets of albumin because five or six fatty acids were bound to DHSA-G2 and even to DHSA-G3 (Fig. 5b). In addition, due to the positive net charge of the dendrons, DHSA-G2 revealed membrane uptake, as observed by confocal microscopy. Also, the cytotoxicity of both dendronized core–shell HSA derivatives was considerably lower than that of PAMAM dendrimers with similar numbers of positive charges. This suggests that protein-based polycations and polymer polycations interact differently with cellular membranes, e.g., the latter might have a higher tendency to induce cell leakage due to hole formation in the membrane. The capacity of DHSA-G2 to accommodate and deliver the lipophilic antitumor drug doxorubicin (DOX) has been further addressed [40]. DHSA-G2 reveals a significantly higher loading compared to native HSA since about 11 DOX molecules are bound tightly even in buffer or cell culture medium. In vitro studies indicate a fast cellular uptake of the DHSA-G2–DOX complexes, and DOX release into the cytosol has been substantiated by the observed high cytotoxicity as well as activation of intracellular caspases 3 and 7, which ultimately leads to apoptosis. Therefore, protein dendronization could potentially be considered an attractive strategy for increasing the molecular weight of a protein to enhance blood circulation, shield epitopes at the protein surface, reduce proteolysis by proteases, and enable drug uptake into the lipophilic interior of albumin.
However, if substantially higher drug loading is required, both the covalent attachment of drugs to the globular HSA protein as well as the non-covalent adsorption into the binding pockets are limited by the available space. In order to further increase the drug loading capacity of HSA, reactive groups within the scaffold of HSA that are normally hidden inside the protein scaffold need to become more accessible for chemical modifications.
1.4 Albumin Copolymer Polyelectrolytes Allow Efficient Drug Delivery
Further exploration of multifunctional protein polyelectrolytes requires the full use of the inner functional groups. However, unfolding of a protein’s tertiary structure often leads to precipitation and destabilization. Recently, an in situ stabilization method has been developed that allows the unfolding of proteins into polypeptide chains and exposure of “hidden” functional groups. This has been achieved by controlled chemical denaturation of the native proteins and an in situ stabilization with PEO chains (Fig. 6a). Different protein precursors (e.g., HSA, BSA, and the protease lysozyme) have been studied to prove the general applicability of this approach [41, 42]. The protein-derived polypeptide side chain copolymers feature precisely defined backbone lengths, large numbers of readily available functional groups, and partially maintained secondary structure elements [41, 42]. Modification of the exposed functional groups allows successful conjugation onto the protein backbone of multiple reactive moieties such as chromophores, anticancer drugs, or MRI contrast agents [43, 44]. Due to the presence of hydrophobic patches along the protein primary sequence, the unfolded albumin-based polypeptides can efficiently interact with hydrophobic molecules. Polymeric micelles are formed where the hydrophilic groups face to the outside, and hydrophobic drug molecules are encapsulated inside these micelles [43, 44]. Via this strategy, several polycationic albumin polypeptides have been reported that displayed efficient cell uptake, low cytotoxicity, fast enzymatic degradation, and multifunctionality [41, 44, 45]. Due to their excellent biocompatibility and high drug loading capacity, they have been developed into various drug delivery systems [44, 45].
The hydrophobic effect that leads to micelle formation in the presence of lipophilic guest molecules can be further enhanced by reacting the protein side chains with additional hydrophobic groups such as ethynyl groups [43, 44]. Via this approach, the anticancer drug DOX [44, 45] and hydrophobic fluorophores such as coumarin [43] and perylenediimide [46] have been encapsulated into the interior of these polycationic micelles and efficiently delivered into cells. The DOX-encapsulating albumin micelles showed great potential as macromolecular anticancer drugs due to their fast cellular uptake, significant cytotoxicity, but low toxicity of the albumin carrier [41, 44].
Furthermore, onion-type multishell drug delivery systems offering a two-step controlled drug release have been developed by the conjugation of high numbers of DOX drug molecules into the albumin interior [44] (Fig. 6b). Specifically, HSA has been equipped with a PEO shell to ensure water solubility under denaturing conditions. Then, the HSA backbone is unfolded as described above to expose cysteine groups for drug conjugation. The anticancer drug DOX is attached to the cysteine residues via an acid-cleavable hydrazone linker. Up to 28 DOX molecules have been uploaded per protein in a reproducible fashion. The protein backbone backfolds after drug loading to form DOX-HSA-PEO multishell micelles with (1) DOX molecules encapsulated inside the core, (2) albumin protein as the enzyme-degradable protecting shell, and (3) PE as water-soluble and immune-silencing shell. This drug delivery system exhibits a controlled two-step drug release mechanism in response to proteolysis and acidic pH environment, therefore reducing undesirable drug leakage. The cell toxicity has been examined in vitro as well as in vivo. A highly potent toxicity effect in an acute myeloid leukemia (AML) model has been observed, with an IC50 in the subnanomolar range, and long-term suppression of AML growth has been observed in a mice model [44]. Furthermore, by modifying the multiple functional groups of the protein shell, additional functionalities, such as MRI contrast reagents, could be further attached to this multishell structure. For instance, the most widely used T1 MRI contrast reagent, Gd-DOTA, has been conjugated to the lysine residues of the protein backbone, thus resulting in a theranostic complex that potentially allows therapeutic drug delivery and diagnostic imaging simultaneously (our unpublished data). In the future, this system offers great potential for developing personalized anticancer therapy.
1.5 Conclusions
Polyelectrolyte interactions play an important role in cell biology. By introducing multiple positive charges into the periphery of fluorescently labeled polyphenylene dendrimers, charge-dependent membrane uptake and cell toxicity was found. In addition, polycationic dendrimers were able to tightly complex and release DNA and stain the extracellular matrix by interacting with the natural aggrecane polyanions. Dendritic polyanions, in contrast, were not able to pass the cellular membrane; however, in fixed cells, tight binding to histone proteins in the cell nucleus was observed, where DNA was most probably displaced from the complexes. Both the polyanionic and polycationic dendritic chromophores specifically stained cellular structures such as the ECM and the cell nucleus, based on the presence of multiple charges within a small nanoscopic volume. In addition, protein polyelectrolytes have been prepared by converting surface-exposed residues into primary amino or carboxylic acid groups. Albumin polycations revealed considerably lower cytotoxicities than their synthetic analogs as well as efficient cell uptake and intracellular release. Complex stoichiometries with DNA could be adjusted by the charge densities of the albumin polycations. Tight DNA binding and efficient transfection was achieved with the highest cationized cBSA derivative.
Cationization of albumin proteins diminished the accessibility of the albumin binding pockets. However, the attachment of positively charged dendrons allowed guest uptake into the hydrophobic binding pockets and efficient delivery of the cytotoxic drug DOX has been achieved. Denaturing the albumin backbone of cationic albumin proteins yields polypeptides that can fold back into micelle structures in the presence of lipophilic guest molecules. These micelles can be taken up by cells due to the presence of multiple positive charges along the polypeptide backbone, which makes them attractive for drug delivery applications. A refined polycationic albumin biopolymer has been prepared that bears many drug molecules attached to the polypeptide backbone. These were protected by the polypeptide as well as by a second PEO shell, allowing a controlled two-step drug release. These polycationic polypeptides offer great potential for drug delivery and simultaneous bioimaging and have already been studied in in vivo experiments.
2 Gene Transfection Utilizing Cationic Cylindrical Brush Polymers
2.1 Introduction
As described above, cationically modified albumin was successfully utilized in gene transfection experiments. A novel cylindrical structure of poly-l-lysine (PLL) in the form of a cylindrical brush polymer with PLL side chains has been utilized for DNA transfection. The results are compared with the transfection efficiency of flexible linear PLL/DNA complexes.
Nonviral gene transfection is a widely used in vitro method for studying gene effects in target cells. However, to date only few successful transfections of brain endothelial cells have been published [47–49]. For example, Zhang et al. describe the transfection of murine brain capillary endothelial cells with short polyamines containing a reducible disulfide backbone [48]. Recently, Chen and colleagues described a successful downregulation of expression (60% reduction) via targeted delivery of siRNA-loaded PLGA nanoparticles [50]. Furthermore, another study compared state-of-the-art transfection approaches and determined that only an electroporation protocol achieved efficient transfection rates of brain capillary cells (82% transfected cells) compared to lipid-based transfection (21–40% transfected cells) [49]. Hence, there is still a high demand for the development of nonviral gene delivery systems, especially for difficult-to-transfect cell lines like brain capillary endothelial cells.
Besides viruses [51–57], various synthetic and biological polycation/DNA complexes have also been utilized as vehicles for gene transport [58–66]. Among others, the effects of the polycation chemical composition, charge density, and chain topology (linear flexible coils, hyperbranched or dendritic structures, comb-like polymers) were investigated [67, 68]. Work on PLL with different chain topologies (linear, branched, dendritic) by Mannistö et al. showed no clear relation between the physicochemical properties (complex size, zeta-potential, condensation of DNA) and the transfection efficiency [69]. However, linear PLL was more efficient for transfection of D407 cell lines than the dendritic or branched polymer.
2.2 Polymers for Transfection
Rod-like, semiflexible, and ring-shaped polymers were claimed to be promising candidates as drug delivery vehicles, showing prolonged in vivo circulation times [70–73] and excellent accumulation in tumor cells [72, 74]. Reports on complexes of stiff polycations with DNA are rare. Besides other reports [75, 76], pullulan modified with spermine groups was reported to transfect T24 cells of a human bladder cancer cell line [77], HepG2 cells of a human hepatoma cell line [78, 79], and human microvascular endothelial cells [80].
Cylindrical brush polymers [81–88] constitute a prominent class of worm-like cylindrical polymers, which consist of a long main chain (degree of polymerization P n > 500) densely decorated with short polymeric side chains (20 < P n < 100). Due to the extremely large grafting density (typically one side chain per 0.25–0.5 nm main chain contour length) the steric repulsion of the side chains forces the main chain into an extended conformation with a persistence length comparable to that of DNA (see Fig. 7).
Such polymer topologies have not been utilized in DNA transfection studies except for one study by Liu et al. [68], who report on brush-like polymers with PEI-b-PEO side chains. However, in these polymers the main chain length was hardly longer than the side chain length, resulting in a spherical rather than cylindrical brush structure.
2.3 Brush Polymer Synthesis and DNA Complexation
The PLL-brush polymers were synthesized by grafting Z-protected lysine by ring-opening polymerization from a macroinitiator, as described elsewhere [87]. The total weight-average molar mass (M w) of the deprotected PLL brush was determined in aqueous 5 mM LiBr by light scattering to be 1.03×107 g/mol, yielding an average of 55 lysine units per side chain [87]. The overall brush dimensions were R g = 84.4 nm and R h = 56.7 nm. The degree of polymerization of the macroinitiator was evaluated by light scattering to be P w = 900. The polydispersity measured by gel permeation chromatography in dimethyl formamide (DMF) was M w/M n = 1.5 (polystyrene calibration). Linear PLL with M w = 326,000 g/mol, R g = 27 nm, and R h = 21 nm was also utilized for complex formation and transfection studies. The DNA/polycation complexes were prepared by adding DNA (pUC19) solution dropwise to a polycation solution.
Complexes can be formed by dropwise addition of DNA solution to the polycation solution. At low excess of polycation, the radii of the complex mixture remain small, in the size regime of either the pure polycation or the DNA. In this part of the phase diagram, complexes are known to coexist with excess polycation [89–91]. When approaching the point where the molar mass and the radii of the complexes start to diverge, the excess component becomes fully incorporated into the complexes. Upon further addition of DNA, the solution becomes unstable due to bridging of the primary complexes by additional DNA. These experiments were performed with pUC19 DNA but similar results are to be expected for the larger GFP-DNA (Fig. 8). For linear PLL, this diverging point lies in the equimolar charge regime, whereas it is shifted to a bigger excess of polycation for brush molecules in qualitative agreement with our former results on similar systems [89]. Above z+/z− = 1.5 for complexes with linear PLL and z+/z− = 2.2 with PLL brushes, no free DNA could be detected.
For transfection experiments, these critical DNA weight fractions (w DNA) limit the choice of mixing ratios to 0.15 < w DNA < 0.2, because w DNA should be well below the diverging point and the solution for transfection should not contain too-large an excess of uncomplexed polycation.
Typically, one complex contains 20 DNA molecules and 10 cylindrical brush molecules, whereas more than 100 linear PLL chains are involved in a complex containing similar numbers of DNA molecules.
For a successful transfection, DNA must be released from complexes. One prominent hypothesis postulates that anionic competitors, most likely polyions, could replace DNA in the complex [92, 93]. Hence, lower molar mass heparin has been established as a model for DNA release experiments, although heparin is not abundant in cells. In addition, the serum protein albumin (which is also not abundant in the cell cytoplasm) as representative of proteins with a small anionic charge, NaCl, and RNA were tested for their ability to release DNA from brush polymers and linear polymers [94]. Results of the release experiments are summarized in Table 1. Complexes with linear PLL were very stable and DNA was not released by any of the applied competitors. In contrast, complexes with brush polymers were less stable and both heparin and BSA were able to release DNA, depending on the excess of competitor to DNA.
Additionally, it was investigated whether complexation of DNA with polycations could guard DNA from degradation by DNase. Degradation assays with DNase revealed that none of the complexes provided enhanced protection against DNase degradation. Recent reports on DNA protection against DNase degradation in Lipofectamine/DNA complexes are controversial [95–98] and do not allow a detailed discussion on the importance of DNase protection on the transfection efficiency.
Whereas the release experiments clearly showed that DNA was more easily released from the cylindrical brush complexes than from linear PLL complexes, experiments with ethidiumbromide revealed that all DNA phosphate groups were complexed by the cationic charges for both linear and cylindrical brush PLLs. Thus, subtle topology-dependent enthalpic and entropic effects may play a deciding role in the DNA release out of the complexes.
2.4 Transfection with Brush Polymers
Prior to transfection, the question of cell cytotoxicity needs to be addressed. Porcine microvascular endothelial cell (PBMEC) viability was affected in a concentration-dependent manner and was similar for linear PLL and cylindrical PLL brushes, with a 50% cell survival concentration of 0.5 mg/mL. For comparison, the cell cytotoxicity of linear PLLs and stiff cylindrical PLL-brush polymers on fibroblasts (NIH/3T3) was also tested, which is known to be very high for linear PLL [99]. These results could be confirmed because linear as well as brush PLL polymers were found to be very toxic for fibroblasts (50% cell survival concentration 0.01 mg/mL). The differences in cytotoxicity between the two cell lines may be explained by cell type-dependent differences. Brain endothelial cells possess transport systems (efflux transporter of ABC family) characteristic for barrier endothelial cells, which constitute a physical barrier to the brain [100]. The PLL-brush polymers showed a 40% reduction in cell viability at a concentration of 0.1 mg/mL and no effect at a concentration of 0.01 mg/mL. PLL brush concentrations used for transfection were <0.1 mg/mL; hence, only moderate effects on cell viability are to be expected during transfection. Compared to the well-known cytotoxic side effects of other transfection reagents (e.g., lipofectins [101]), the moderate effects on cell viability observed here are judged to be of only minor importance.
For in vitro transfection studies, complexes of DNA and cylindrical brush PLL with PLL side chains were formed at a polycation-to-DNA charge ratio of z+/z− = 10.6 and z+/z− = 6.3. [94]. Transfection was controlled by confocal microscopy and quantified by cell cytometry. Only complexes with brush PLL provided significant cell transfection of brain capillary endothelial cells (PBMEC), whereas complexes with linear PLL were not effective, as shown in Fig. 9.
It was demonstrated that cylindrical brush/DNA complexes showed the highest transfection efficiencies, even higher than for Lipofectamine controls. Quantitative analysis revealed that cylindrical brush/DNA complexes formed at an excess of 6.3 and 10.6 positive charges per negative charge (z+/z−) evoked an increase in transfection efficiency of 50±18.2% and 44±12.4% (compared to Lipofectamine) whereas similar complexes with linear PLL did not lead to any significant transfection (Fig. 9), although the size of the complexes was similar (80 nm < R h < 150 nm).
2.5 Conclusions
Developing an effective delivery agent for the transfection of challenging cells like capillary endothelial cells is a major experimental problem in in vitro experiments. The results of the studies described here demonstrate that the worm-like topology of synthetic polycations shows superior transfection results as compared to chemically similar linear polycations. PLL-based polycations are known to be toxic for many cell lines, although PBMEC were shown to survive amazingly high concentrations of PLL, up to 0.1 mg/mL. Accordingly, future work will aim to reduce cytotoxicity, for instance by reducing the number of cationic charges. The cylindrical brush polymers presented here have the additional advantage that they can be prepared from a variety of chemically different biocompatible and biodegradable building blocks. The latter option may eventually lead to in vivo applications, provided that the release of DNA by interaction with serum proteins can be prohibited.
Abbreviations
- AML:
-
Acute myeloid leukemia
- ATRP:
-
Atom transfer radical polymerization
- cBSA:
-
Cationized bovine serum albumin
- DHSA:
-
Dendronized human serum albumin
- DMF:
-
Dimethyl formamide
- DOX:
-
Doxorubicin
- ECM:
-
Extracellular matrix
- EPR:
-
Enhanced retention and permeation
- GFP:
-
Green fluorescent protein
- HSA:
-
Human serum albumin
- LiBr:
-
Lithium bromide
- MRI:
-
Magnetic resonance imaging
- M w :
-
Weight-average molecular weight
- NaCl:
-
Sodium chloride
- PAMAM:
-
Polyamidoamine
- PBMEC:
-
Porcine microvascular endothelial cells
- PDI:
-
Perylene-3,4,9,10-tetracarboxdiimide
- PEG:
-
Poly(ethylene glycol)
- PEI:
-
Poly(ethylene imine)
- PEO:
-
Poly(ethylene oxide)
- PLL:
-
Poly-l-lysine
- P n :
-
Number-average degree of polymerization
- P w :
-
Weight-average degree of polymerization
- R g :
-
Radius of gyration
- R h :
-
Hydrodynamic radius
- TEM:
-
Transmission electron microscopy
- w DNA :
-
Weight fraction of DNA
- z +/z − :
-
Molar charge ratio polycation/polyanion
References
Rejman J, Conese M, Hoekstra D (2006) Gene transfer by means of lipo- and polyplexes: role of clathrin and caveolae-mediated endocytosis. J Liposome Res 16:237–247. doi:10.1080/08982100600848819
Kumari S, Mg S, Mayor S (2010) Endocytosis unplugged: multiple ways to enter the cell. Cell Res 20:256–275. doi:10.1038/cr.2010.19
McGhee JD, Felsenfeld G (1980) The number of charge-charge interactions stabilizing the ends of nucleosome DNA. Nucleic Acids Res 8:2751–2769
Thomas M, Lu JJ, Zhang C et al (2007) Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library. Pharm Res 24:1564–1571. doi:10.1007/s11095-007-9279-3
Zhu J-L, Cheng H, Jin Y et al (2008) Novel polycationic micelles for drug delivery and gene transfer. J Mater Chem 18:4433. doi:10.1039/b801249k
Eisele K, Gropeanu RA, Zehendner CM et al (2010) Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147. Biomaterials 31:8789–8801. doi:10.1016/j.biomaterials.2010.07.088
Gillies ER, Fréchet JMJ (2005) Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 10:35–43. doi:10.1016/S1359-6446(04)03276-3
Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377:159–169. doi:10.1042/BJ20031253
Sahay G, Alakhova DY, Kabanov AV (2010) Endocytosis of nanomedicines. J Control Release 145:182–195. doi:10.1016/j.jconrel.2010.01.036
Panyam J, Labhasetwar V (2003) Dynamics of endocytosis and exocytosis of poly(d, l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 20:212–220
Nan A, Bai X, Son SJ et al (2008) Cellular uptake and cytotoxicity of silica nanotubes. Nano Lett 8:2150–2154. doi:10.1021/nl0802741
Huang M, Ma Z, Khor E, Lim L-Y (2002) Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 19:1488–1494
Parton RG, Simons K (2007) The multiple faces of caveolae. Nat Rev Mol Cell Biol 8:185–194. doi:10.1038/nrm2122
Sahay G, Kim JO, Kabanov AV, Bronich TK (2010) The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. Biomaterials 31:923–933. doi:10.1016/j.biomaterials.2009.09.101
Nishikawa T, Iwakiri N, Kaneko Y et al (2009) Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. Biomacromolecules 10:2074–2085. doi:10.1021/bm900128x
Zhang LW, Monteiro-Riviere NA (2009) Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol Sci 110:138–155. doi:10.1093/toxsci/kfp087
Gradishar WJ (2006) Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother 7:1041–1053. doi:10.1517/14656566.7.8.1041
Yin M, Kuhlmann CRW, Sorokina K et al (2008) Novel fluorescent core–shell nanocontainers for cell membrane transport. Biomacromolecules 9:1381–1389. doi:10.1021/bm701138g
Parimi S, Barnes TJ, Callen DF, Prestidge CA (2010) Mechanistic insight into cell growth, internalization, and cytotoxicity of PAMAM dendrimers. Biomacromolecules 11:382–389. doi:10.1021/bm9010134
Yin M, Shen J, Gropeanu R et al (2008) Fluorescent core/shell nanoparticles for specific cell-nucleus staining. Small 4:894–898. doi:10.1002/smll.200701107
Hedlund H, Hedbom E, Heine grd D et al (1999) Association of the aggrecan keratan sulfate-rich region with collagen in bovine articular cartilage. J Biol Chem 274:5777–5781
Hardingham TE, Fosang AJ, Dudhia J (1994) The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage. Eur J Clin Chem Clin Biochem 32:249–257
Yin M, Ding K, Gropeanu RA et al (2008) Dendritic star polymers for efficient DNA binding and stimulus-dependent DNA release. Biomacromolecules 9:3231–3238. doi:10.1021/bm800797j
Ng JF, Jaenicke S, Eisele K et al (2010) cBSA-147 for the preparation of bacterial biofilms in a microchannel reactor. Biointerphases 5:FA41–FA47. doi:10.1116/1.3474475
Ritz S, Eisele K, Dorn J et al (2010) Cationized albumin-biocoatings for the immobilization of lipid vesicles. Biointerphases 5:FA78–FA87. doi:10.1116/1.3494039
Ng JF, Weil T, Jaenicke S (2011) Cationized bovine serum albumin with pendant RGD groups forms efficient biocoatings for cell adhesion. J Biomed Mater Res B Appl Biomater 99:282–290. doi:10.1002/jbm.b.31897
Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–6392
Kratz F (2002) Drug conjugates with albumin and transferrin. Expert Opin Ther Pat 12:433–439. doi:10.1517/13543776.12.3.433
Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207
Elsadek B, Kratz F (2012) Impact of albumin on drug delivery – new applications on the horizon. J Control Release 157:4–28. doi:10.1016/j.jconrel.2011.09.069
Neumann E, Frei E, Funk D et al (2010) Native albumin for targeted drug delivery. Expert Opin Drug Deliv 7:915–925. doi:10.1517/17425247.2010.498474
Varshney A, Sen P, Ahmad E et al (2010) Ligand binding strategies of human serum albumin: how can the cargo be utilized? Chirality 22:77–87. doi:10.1002/chir.20709
Paál K, Müller J, Hegedûs L (2001) High affinity binding of paclitaxel to human serum albumin. Eur J Biochem 268:2187–2191
Xu R, Fisher M, Juliano RL (2011) Targeted albumin-based nanoparticles for delivery of amphipathic drugs. Bioconjug Chem 22:870–878. doi:10.1021/bc1002295
Sun H-H, Zhang J, Zhang Y-Z et al (2012) Interaction of human serum albumin with 10-hydroxycamptothecin: spectroscopic and molecular modeling studies. Mol Biol Rep 39:5115–5123. doi:10.1007/s11033-011-1307-z
Vis AN, Van der Gaast A, Van Rhijn BWG et al (2002) A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy. Cancer Chemother Pharmacol 49:342–345. doi:10.1007/s00280-001-0417-z
Akdogan Y, Wu Y, Eisele K et al (2012) Host–guest interactions in polycationic human serum albumin bioconjugates. Soft Matter 8:11106. doi:10.1039/c2sm26511g
Kitchens KM, Kolhatkar RB, Swaan PW, Ghandehari H (2008) Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells. Mol Pharm 5:364–369. doi:10.1021/mp700089s
Kitchens KM, Foraker AB, Kolhatkar RB et al (2007) Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res 24:2138–2145. doi:10.1007/s11095-007-9415-0
Kuan SL, Stöckle B, Reichenwallner J et al (2013) Dendronized albumin core-shell transporters with high drug loading capacity. Biomacromolecules 14:367–376. doi:10.1021/bm301531c
Wu Y, Pramanik G, Eisele K, Weil T (2012) Convenient approach to polypeptide copolymers derived from native proteins. Biomacromolecules 13:1890–1898. doi:10.1021/bm300418r
Wu Y, Weil T (2012) An efficient approach for preparing giant polypeptide triblock copolymers by protein dimerization. Macromol Rapid Comm 33:1304–1309. doi:10.1002/marc.201200111
Wu Y, Wang T, Ng DYW, Weil T (2012) Multifunctional polypeptide-PEO nanoreactors via the hydrophobic switch. Macromol Rapid Comm 33:1474–1481. doi:10.1002/marc.201200227
Wu Y, Ihme S, Feuring-Buske M et al (2012) A core-shell albumin copolymer nanotransporter for high capacity loading and two-step release of doxorubicin with enhanced anti-leukemia activity. Adv Healthc Mater 2:884–894. doi:10.1002/adhm.201200296
Wu Y, Shih EK, Ramanathan A et al (2012) Nano-sized albumin-copolymer micelles for efficient doxorubicin delivery. Biointerphases 7:5. doi:10.1007/s13758-011-0005-7
Eisele K, Gropeanu R, Musante A et al (2010) Tailored albumin-based copolymers for receptor-mediated delivery of perylenediimide guest molecules. Macromol Rapid Commun 31:1501–1508. doi:10.1002/marc.201000176
Zhang H, Vinogradov SV (2010) Short biodegradable polyamines for gene delivery and transfection of brain capillary endothelial cells. J Control Release 143:359–366. doi:10.1016/j.jconrel.2010.01.020
Zhang H, Mitin A, Vinogradov SV (2009) Efficient transfection of blood–brain barrier endothelial cells by lipoplexes and polyplexes in the presence of nuclear targeting NLS-PEG-acridine conjugates. Bioconjug Chem 20:120–128. doi:10.1021/bc8003414
Slanina H, Schmutzler M, Christodoulides M et al (2012) Effective plasmid DNA and small interfering RNA delivery to diseased human brain microvascular endothelial cells. J Mol Microbiol Biotechnol 22:245–257. doi:10.1159/000342909
Chen C, Mei H, Shi W et al (2013) EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference. PLoS One 8:e60860. doi:10.1371/journal.pone.0060860
McTaggart S, Al-Rubeai M (2002) Retroviral vectors for human gene delivery. Biotechnol Adv 20:1–31
Verma IM, Weitzman MD (2005) Gene therapy: twenty-first century medicine. Annu Rev Biochem 74:711–738. doi:10.1146/annurev.biochem.74.050304.091637
Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7:33–40. doi:10.1038/83324
Wong HH, Lemoine NR, Wang Y (2010) Oncolytic viruses for cancer therapy: overcoming the obstacles. Viruses 2:78–106. doi:10.3390/v2010078
Nayak S, Herzog RW (2010) Progress and prospects: immune responses to viral vectors. Gene Ther 17:295–304. doi:10.1038/gt.2009.148
Van den Pol AN, Ozduman K, Wollmann G et al (2009) Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expression. J Comp Neurol 516:456–481. doi:10.1002/cne.22131
Lim ST, Airavaara M, Harvey BK (2010) Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res 61:14–26. doi:10.1016/j.phrs.2009.10.002
Kabanov AV (1999) Taking polycation gene delivery systems from in vitro to in vivo. Pharm Sci Technolo Today 2:365–372
El-Aneed A (2004) An overview of current delivery systems in cancer gene therapy. J Control Release 94:1–14
Thomas M, Klibanov AM (2003) Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol 62:27–34. doi:10.1007/s00253-003-1321-8
Ditto AJ, Shah PN, Yun YH (2009) Non-viral gene delivery using nanoparticles. Expert Opin Drug Deliv 6:1149–1160. doi:10.1517/17425240903241796
Conwell CC, Huang L (2005) Recent advances in non-viral gene delivery. Adv Genet 53PA:1–18. doi:10.1016/S0065-2660(05)53001-3
Salcher EE, Wagner E (2010) Chemically programmed polymers for targeted DNA and siRNA transfection. Top Curr Chem 296:227–249
Ogris M (2010) Cancer gene therapies come of age. Ther Deliv 1:211–214
Yu H, Wagner E (2009) Bioresponsive polymers for nonviral gene delivery. Curr Opin Mol Ther 11:165–178
Oba M, Miyata K, Osada K et al (2011) Polyplex micelles prepared from ω-cholesteryl PEG-polycation block copolymers for systemic gene delivery. Biomaterials 32:652–663. doi:10.1016/j.biomaterials.2010.09.022
Benns JM, Choi JS, Mahato RI et al (2000) pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(l-histidine)-graft-poly(l-lysine) comb shaped polymer. Bioconjug Chem 11:637–645
Liu X-Q, Du J-Z, Zhang C-P et al (2010) Brush-shaped polycation with poly(ethylenimine)-b-poly(ethylene glycol) side chains as highly efficient gene delivery vector. Int J Pharm 392:118–126. doi:10.1016/j.ijpharm.2010.03.043
Männistö M, Vanderkerken S, Toncheva V et al (2002) Structure-activity relationships of poly(l-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. J Control Release 83:169–182
Geng Y, Dalhaimer P, Cai S et al (2007) Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2:249–255. doi:10.1038/nnano.2007.70
Liu Z, Davis C, Cai W et al (2008) Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci U S A 105:1410–1415. doi:10.1073/pnas.0707654105
Fox ME, Szoka FC, Fréchet JMJ (2009) Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res 42:1141–1151. doi:10.1021/ar900035f
Lee CC, Yoshida M, Fréchet JMJ et al (2005) In vitro and in vivo evaluation of hydrophilic dendronized linear polymers. Bioconjug Chem 16:535–541. doi:10.1021/bc0497665
Johnson JA, Lu YY, Burts AO et al (2010) Drug-loaded, bivalent-bottle-brush polymers by graft-through ROMP. Macromolecules 43:10326–10335. doi:10.1021/ma1021506
Jo J, Okazaki A, Nagane K et al (2010) Preparation of cationized polysaccharides as gene transfection carrier for bone marrow-derived mesenchymal stem cells. J Biomater Sci Polym Ed 21:185–204. doi:10.1163/156856209X415495
Thakor DK, Teng YD, Tabata Y (2009) Neuronal gene delivery by negatively charged pullulan-spermine/DNA anioplexes. Biomaterials 30:1815–1826. doi:10.1016/j.biomaterials.2008.12.032
Kanatani I, Ikai T, Okazaki A et al (2006) Efficient gene transfer by pullulan-spermine occurs through both clathrin- and raft/caveolae-dependent mechanisms. J Control Release 116:75–82. doi:10.1016/j.jconrel.2006.09.001
Jo J, Ikai T, Okazaki A et al (2007) Expression profile of plasmid DNA by spermine derivatives of pullulan with different extents of spermine introduced. J Control Release 118:389–398. doi:10.1016/j.jconrel.2007.01.005
Jo J-I, Ikai T, Okazaki A et al (2007) Expression profile of plasmid DNA obtained using spermine derivatives of pullulan with different molecular weights. J Biomater Sci Polym Ed 18:883–899. doi:10.1163/156856207781367756
Thomsen LB, Lichota J, Kim KS, Moos T (2011) Gene delivery by pullulan derivatives in brain capillary endothelial cells for protein secretion. J Control Release 151:45–50. doi:10.1016/j.jconrel.2011.01.002
Wintermantel M, Schmidt M, Tsukahara Y et al (1994) Rodlike combs. Macromol Rapid Comm 15:279–284. doi:10.1002/marc.1994.030150315
Wintermantel M, Gerle M, Fischer K et al (1996) Molecular bottlebrushes†. Macromolecules 29:978–983. doi:10.1021/ma950227s
Dziezok P, Fischer K, Schmidt M et al (1997) Cylindrical molecular brushes. Angew Chem Int Ed 36:2812–2815. doi:10.1002/anie.199728121
Sheiko SS, Gerle M, Fischer K et al (1997) Wormlike polystyrene brushes in thin films. Langmuir 13:5368–5372. doi:10.1021/la970132e
Gerle M, Fischer K, Roos S et al (1999) Main chain conformation and anomalous elution behavior of cylindrical brushes as revealed by GPC/MALLS, light scattering, and SFM‡. Macromolecules 32:2629–2637. doi:10.1021/ma9816463
Zhang B, Gröhn F, Pedersen JS et al (2006) Conformation of cylindrical brushes in solution: effect of side chain length. Macromolecules 39:8440–8450. doi:10.1021/ma0613178
Sahl M, Muth S, Branscheid R et al (2012) Helix–coil transition in cylindrical brush polymers with poly-l-lysine side chains. Macromolecules 45:5167–5175. doi:10.1021/ma300377v
Zhang B, Fischer K, Schmidt M (2005) Cylindrical polypeptide brushes. Macromol Chem Phys 206:157–162. doi:10.1002/macp.200400266
Störkle D, Duschner S, Heimann N et al (2007) Complex formation of DNA with oppositely charged polyelectrolytes of different chain topology: cylindrical brushes and dendrimers. Macromolecules 40:7998–8006. doi:10.1021/ma0711689
Boeckle S, Von Gersdorff K, Van der Piepen S et al (2004) Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J Gene Med 6:1102–1111. doi:10.1002/jgm.598
Yue Y, Jin F, Deng R et al (2011) Revisit complexation between DNA and polyethylenimine – effect of uncomplexed chains free in the solution mixture on gene transfection. J Control Release 155:67–76. doi:10.1016/j.jconrel.2010.10.028
Bertschinger M, Backliwal G, Schertenleib A et al (2006) Disassembly of polyethylenimine-DNA particles in vitro: implications for polyethylenimine-mediated DNA delivery. J Control Release 116:96–104. doi:10.1016/j.jconrel.2006.09.006
Moret I, Esteban Peris J, Guillem VM et al (2001) Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum. J Control Release 76:169–181
Kühn F (2010) Polykation-DNA-komplexe: eigenschaften und anwendungen in der gentransfektion. Dissertation, Johannes Gutenberg-Universität Mainz
Li P, Liu D, Sun X et al (2011) A novel cationic liposome formulation for efficient gene delivery via a pulmonary route. Nanotechnology 22:245104. doi:10.1088/0957-4484/22/24/245104
Buzder T, Yin X, Wang X et al (2009) Uptake of foreign nucleic acids in kidney tubular epithelial cells deficient in proapoptotic endonucleases. DNA Cell Biol 28:435–442. doi:10.1089/dna.2008.0850
Gadi J, Ruthala K, Kong K-A et al (2009) The third helix of the Hoxc8 homeodomain peptide enhances the efficiency of gene transfer in combination with lipofectamine. Mol Biotechnol 42:41–48. doi:10.1007/s12033-008-9119-7
Howell DP-G, Krieser RJ, Eastman A, Barry MA (2003) Deoxyribonuclease II is a lysosomal barrier to transfection. Mol Ther 8:957–963
Fischer D, Li Y, Ahlemeyer B et al (2003) In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24:1121–1131
Mahringer A, Ott M, Reimold I et al (2011) The ABC of the blood–brain barrier – regulation of drug efflux pumps. Curr Pharm Des 17:2762–2770
Uchida E, Mizuguchi H, Ishii-Watabe A, Hayakawa T (2002) Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells. Biol Pharm Bull 25:891–897
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hedrich, J. et al. (2013). Polymer Complexes in Biological Applications. In: Basché, T., Müllen, K., Schmidt, M. (eds) From Single Molecules to Nanoscopically Structured Materials. Advances in Polymer Science, vol 260. Springer, Cham. https://doi.org/10.1007/12_2013_229
Download citation
DOI: https://doi.org/10.1007/12_2013_229
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-05827-6
Online ISBN: 978-3-319-05828-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)